Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organizati ...

Investor Presentation (Nasdaq: MRVI) May 2021 eSciences Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this presentation which are not strictly historical statements constitute forward-looking statements, including, w ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organizat ...

Q1 2021 Financial Results (Nasdaq: MRVI) May 10, 2021 eSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 Q&A Session 04 2 Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make, "forward-looking statements" within the meaning of the safe harbor provis ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2021 Earnings Conference Call May 10, 2021 5:00 PM ET Company Participants Deb Hart - Investor Relations Carl Hull - Chairman and Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Matt Larew - William Blair Derik De Bruin - Bank of America Dan Brennan - UBS Operator Good day and thank you for standing by. Welcome to the Q1 2021 M ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2020 Earnings Conference Call March 2, 2021 5:00 PM ET Company Participants Debra Hart - Senior Director, IR Carl Hull - Partner, Co-Founder, CEO Kevin Herde - VP, CFO Eric Tardif - Partner, Co-Founder, President Conference Call Participants Tejas Savant - Morgan Stanley Matthew Sykes - Goldman Sachs Brandon Couillard - Jefferies Matt Larew - William Blair Catherine Schulte - Baird Erin Wright - Credit Sussie Dan Brennan - UBS Michael Ryskin - Bank of Ame ...